← FDA DRUG APPROVALS

FDA ANDA · ANDA065254

CLINDAMYCIN PHOSPHATE

Sponsor: FOUGERA PHARMS

APPLICATION
ANDA065254
TYPE
ANDA
ORIGINAL APPROVAL
2006-02-14
LATEST ACTION
2020-03-19
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

CLINDAMYCIN PHOSPHATEDiscontinued
CLINDAMYCIN PHOSPHATE EQ 1% BASE · SOLUTION · TOPICAL

Approval history

2020-03-19Labeling · Supplement 3 · standardAP
2020-03-19Labeling · Supplement 4 · standardAP
2006-02-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →